New blood test could predict lung cancer return after surgery
NCT ID NCT05557474
Summary
This study aims to validate two new test kits designed to identify which early-stage lung cancer patients are at highest risk of their cancer returning after surgery. Researchers will test these kits on 236 patients who have had their lung tumors completely removed. The goal is to create better tools that help doctors predict recurrence risk and guide treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chung Shan Medical University Hospital
RECRUITINGTaichung, Taiwan, 402, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Taiwan University, Cancer Center
RECRUITINGTaipei, 106, Taiwan
Contact
Conditions
Explore the condition pages connected to this study.